Lucatumumab
Lucatumumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Trade Name | Lucatumumab |
Generic | Lucatumumab |
Lucatumumab Other Names | Lucatumumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in leukemia (lymphoid), multiple myeloma, and lymphoma (unspecified).
How Lucatumumab works
HCD122 is a fully human, antagonist antibody that targets the CD40 antigen. HCD122 binds to tumor cells that express CD40 and antagonizes (prevents) CD40 ligand-mediated growth and survival of malignant B cells. Based on preclinical data, HCD122 also induces antibody-dependent cellular cytotoxicity (ADCC), killing CD40 expressing tumor cells by immune effector cells. This dual mechanism of action makes HCD122 a drug candidate with potential for the treatment of B-cell malignancies.
Innovators Monograph
You find simplified version here Lucatumumab